<p>Extensive research has been conducted on epigallocatechin and epigallocatechin-3-gallate, common polyphenols found in green tea, focusing on their structural modifications and broad medicinal uses. Chemists specializing in pharmaceuticals have created analogues for epigallocatechin and epigallocatechin-3-gallate, offering multiple therapeutic activities, including anti-cancer, antiviral, antioxidant, low blood sugar, central nervous system, and anti-inflammatory potential. Concurrently, the structure–activity relationship analysis field has steadily increased, leading to the development of numerous derivatives for prospective targets. This paper offers a detailed overview of the biological functions and structure–activity relationship of epigallocatechin and epigallocatechin-3-gallate analogues, aiming to provide a comprehensive review and outlook on epigallocatechin and epigallocatechin-3-gallate analogs.</p> Graphic Abstract <p></p>

错误:搜索内容不能为空,请输入英文关键词
错误:关键词超出字数限制,请精简
高级检索

Bioactivity and Structure–Activity Relationship of Epigallocatechin and Epigallocatechin-3-Gallate Derivatives

  • Mengchen Lei,
  • Zefeng Zhao,
  • Xiaoan Li,
  • Haifa Qiao,
  • Wenxia Zhou

摘要

Extensive research has been conducted on epigallocatechin and epigallocatechin-3-gallate, common polyphenols found in green tea, focusing on their structural modifications and broad medicinal uses. Chemists specializing in pharmaceuticals have created analogues for epigallocatechin and epigallocatechin-3-gallate, offering multiple therapeutic activities, including anti-cancer, antiviral, antioxidant, low blood sugar, central nervous system, and anti-inflammatory potential. Concurrently, the structure–activity relationship analysis field has steadily increased, leading to the development of numerous derivatives for prospective targets. This paper offers a detailed overview of the biological functions and structure–activity relationship of epigallocatechin and epigallocatechin-3-gallate analogues, aiming to provide a comprehensive review and outlook on epigallocatechin and epigallocatechin-3-gallate analogs.

Graphic Abstract